Dimensional Fund Advisors’s Spruce Biosciences SPRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$426K Sell
8,788
-25
-0.3% -$1.27K ﹤0.01% 2960
2026
Q2
$477K Buy
+8,813
New +$493K ﹤0.01% 2972
2024
Q2
– Sell
-622
Closed -$36.7K – 3420
2024
Q1
$36.7K Buy
+622
New +$158K ﹤0.01% 3345
2023
Q4
– Sell
-433
Closed -$73.3K – 3464
2023
Q3
$73.3K Hold
433
– – ﹤0.01% 3349
2023
Q2
$69.7K Sell
433
-89
-17% -$14.9K ﹤0.01% 3375
2023
Q1
$86.6K Buy
+522
New +$97K ﹤0.01% 3323
2022
Q3
$16K Buy
+157
New +$21.9K ﹤0.01% 3471

Other funds holding SPRB

Dimensional Fund Advisors's SPRB Position: Q3 2026 in Review

Dimensional Fund Advisors reduced its Spruce Biosciences (SPRB) stake by 0.28% in Q3 2026, selling an estimated $1.27K and leaving 8,788 shares worth $426K. The position accounts for ﹤0.01% of the portfolio, ranked #2960.

Dimensional Fund Advisors first reported a position in SPRB in Q3 2022 and has held it in 7 quarters since. The position peaked at $477K in Q2 2026. 19 funds tracked by Wall St. Rank hold SPRB as of Q3 2026.

  • Dimensional Fund Advisors held 8,788 shares of Spruce Biosciences worth $426K as of Q3 2026.
  • Dimensional Fund Advisors sold 25 Spruce Biosciences shares in Q3 2026, an estimated $1.27K.
  • Spruce Biosciences made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2960 holding.
  • Dimensional Fund Advisors first reported a position in Spruce Biosciences in Q3 2022 and has held it in 7 quarters since.
  • Dimensional Fund Advisors's Spruce Biosciences position peaked at $477K in Q2 2026.
  • 19 funds tracked by Wall St. Rank held Spruce Biosciences as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.